Since its incorporation in March 2017, ARES has established an international team of highly committed business and technology experts with proven innovation & commercialization track-record.
Together, and supported by our global partner network, we are working towards revolutionizing infectious disease diagnostics and therapeutics.
- Dr. Arne MaternaManaging Director & CEO
- Dr. Stephan BeiskenManaging Director & Director, Bioinformatics & Analytics
- Dr. Johannes WeinbergerDirector, NGS Laboratory
- Theo deVosSenior Vice President, Corporate Development and Operations (US)
- Faranak AtrzadehHead of Market Access USA